SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (272)11/27/2001 6:48:37 AM
From: nigel bates  Respond to of 1022
 
I didn't really want to run a profitable company

Plenty of other opportunities in the sector. <g>

nig



To: Icebrg who wrote (272)11/28/2001 7:47:14 AM
From: Icebrg  Read Replies (1) | Respond to of 1022
 
Boehringer Ingelheim and ImmunoGen Sign Exclusive License Agreement

New Product, BIWI1, Combines ImmunoGen's Proprietary DM1 Effector Molecule with a Boehringer Ingelheim Antibody

Message 16712423